{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Safingol",
  "nciThesaurus": {
    "casRegistry": "15639-50-6",
    "chebiId": "",
    "chemicalFormula": "C18H39NO2",
    "definition": "A saturated derivative of sphingosine. As an inhibitor of protein kinase C (PKC), safingol competitively binds to the regulatory phorbol-binding domain of PKC, a kinase involved in tumorigenesis. This agent has been shown to act synergistically with other chemotherapeutic agents and may potentiate chemotherapy drug-induced apoptosis in vitro and in vivo.",
    "fdaUniiCode": "OWA98U788S",
    "identifier": "C1568",
    "preferredName": "Safingol",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2089"
    ],
    "synonyms": [
      "(2S,3S)-2-Amino-1,3-Octadecanediol",
      "Kynacyte",
      "L-(-)-threo-Sphingnine",
      "L-Threo-Dihydrosphingosine",
      "L-threo-2-Amino-1,3-octadecanediol",
      "L-threo-dihydrosphingosine",
      "SAFINGOL",
      "SPC-100270",
      "Safingol",
      "Sphinganine",
      "safingol"
    ]
  }
}